© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
May 09, 2017
Should clinicians be extra vigilant when deciding who receives antiviral therapy, or are the adverse effects few and infrequent?
FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention
First In-Africa Clinical Trial of mRNA HIV Vaccine
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality